---
title: "Argent Biopharma Issues Convertible Notes and Unlisted Options"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/268384560.md"
description: "Argent Biopharma Limited has issued 3,300,000 convertible notes and 21,950,952 unlisted options exercisable at A$0.1025, expiring on December 3, 2028. This move is part of a previously announced transaction aimed at strengthening its financial position and enhancing market operations. The company operates in the biotechnology industry, focusing on pharmaceutical products development and commercialization."
datetime: "2025-12-03T08:48:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/268384560.md)
  - [en](https://longbridge.com/en/news/268384560.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/268384560.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/268384560.md) | [繁體中文](https://longbridge.com/zh-HK/news/268384560.md)


# Argent Biopharma Issues Convertible Notes and Unlisted Options

### TipRanks Cyber Monday Sale

-   Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
-   Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off

Argent Biopharma ( (AU:RGT) ) has issued an announcement.

Argent Biopharma Limited announced the issuance of 3,300,000 convertible notes and 21,950,952 unlisted options exercisable at A$0.1025, expiring on December 3, 2028. This move is part of a previously announced transaction and reflects the company’s strategic efforts to strengthen its financial position and enhance its market operations.

**More about Argent Biopharma**

Argent Biopharma Limited operates in the biotechnology industry, focusing on the development and commercialization of pharmaceutical products.

**Average Trading Volume:** 87,148

**Technical Sentiment Signal:** Strong Sell

**Current Market Cap:** A$5.91M

See more insights into RGT stock on TipRanks’ Stock Analysis page.

## Related News & Research

- [Survival Tips for Retail Options Sellers to Manage Risk](https://longbridge.com/en/news/279802381.md)
- [WT Financial Group Options Expire Unexercised, Trimming Potential Dilution](https://longbridge.com/en/news/279179021.md)
- [Tartana Minerals clarifies structure and approvals for $2.85m in convertible notes](https://longbridge.com/en/news/279372274.md)
- [On the Beach CMO Exercises LTIP Options and Sells Shares to Cover Tax](https://longbridge.com/en/news/279580791.md)
- [Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update | TBPH Stock News](https://longbridge.com/en/news/279788810.md)